Recombinant human follicle-stimulating hormone produces more oocytes with a lower total dose per cycle in assisted reproductive technologies compared with highly purified human menopausal gonadotrophin: a meta-analysis

Lehert, Philippe;Schertz, Joan;Ezcurra, Diego
(2010) Reproductive Biology and Endocrinology — Vol. 8, n° 112, p. 1-12 (2010)

Files

1477-7827-8-112.pdf
  • Open Access
  • Adobe PDF
  • 931.5 KB
Download

Details

Authors
  • Lehert, Philippeorcid-logoFUCaM
    Author
  • Schertz, Joan
    Author
  • Ezcurra, Diego
    Author
Affiliations
  • Louvain School of ManagementOperations and Information
  • FUCaMSciences de gestion
  • FUCaM autreFUCaM autre
  • FUCaM autreFUCaM autre

Citations

  • APA
  • Chicago
  • FWB

Lehert, P., Schertz, J., & Ezcurra, D. (2010). Recombinant human follicle-stimulating hormone produces more oocytes with a lower total dose per cycle in assisted reproductive technologies compared with highly purified human menopausal gonadotrophin: a meta-analysis. Reproductive Biology and Endocrinology, 8(112), 1-12. https://doi.org/10.1186/1477-7827-8-112 (Original work published 2010)